fda compounding glp-1 enforcement news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Compounding: When Innovation May

These processes consume time and resources, and they can delay treatment initiation

GLP-1 Medications for Weight Loss: How to Get Started If youre considering a prescription weight-loss medication like Wegovy or Zepbound, the first question is often a practical one: Where do I startand with whom

For Hashimoto's patients, this dual action is particularly relevant

In fact, fat-free mass lost accounts for 25-40% of the total pounds lost, while age-related declines in fat-free mass are only 8% per decade

5, 6 Furthermore, non-clinical and clinical studies have demonstrated increased satiety, reduced food intake and subsequent reductions in body weight following administration of GLP-1, 7, 8 leading to investigations into its potential for the treatment of obesity